RS52492B - MOLECULES WHICH INTERSPECIALLY SPECIFICALLY BISPECIFICALLY Bind - Google Patents

MOLECULES WHICH INTERSPECIALLY SPECIFICALLY BISPECIFICALLY Bind

Info

Publication number
RS52492B
RS52492B RS20120412A RSP20120412A RS52492B RS 52492 B RS52492 B RS 52492B RS 20120412 A RS20120412 A RS 20120412A RS P20120412 A RSP20120412 A RS P20120412A RS 52492 B RS52492 B RS 52492B
Authority
RS
Serbia
Prior art keywords
epitope
species
cross
binding
specific bispecific
Prior art date
Application number
RS20120412A
Other languages
English (en)
Serbian (sr)
Inventor
Matthias Klinger
Tobias Raum
Doris Rau
Roman Kischel
Ralf LUTTERBĂśSE
Patrick Hoffmann
Peter Kufer
Susanne Mangold
Original Assignee
Amgen Research (Munich) Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Research (Munich) Gmbh filed Critical Amgen Research (Munich) Gmbh
Priority claimed from PCT/EP2008/002663 external-priority patent/WO2008119566A2/en
Publication of RS52492B publication Critical patent/RS52492B/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
RS20120412A 2007-04-03 2008-04-03 MOLECULES WHICH INTERSPECIALLY SPECIFICALLY BISPECIFICALLY Bind RS52492B (en)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
EP07006990 2007-04-03
EP07006988 2007-04-03
US91366807P 2007-04-24 2007-04-24
EP07020640 2007-10-22
EP07020641 2007-10-22
EP07020646 2007-10-22
EP08004741 2008-03-13
PCT/EP2008/002663 WO2008119566A2 (en) 2007-04-03 2008-04-03 Cross-species-specific bispecific binders

Publications (1)

Publication Number Publication Date
RS52492B true RS52492B (en) 2013-02-28

Family

ID=42582614

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20120412A RS52492B (en) 2007-04-03 2008-04-03 MOLECULES WHICH INTERSPECIALLY SPECIFICALLY BISPECIFICALLY Bind

Country Status (8)

Country Link
JP (1) JP2010524435A (ru)
DK (1) DK2155788T3 (ru)
ES (1) ES2390243T3 (ru)
NZ (1) NZ580746A (ru)
PT (1) PT2155788E (ru)
RS (1) RS52492B (ru)
RU (1) RU2535992C2 (ru)
SI (1) SI2155788T1 (ru)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2009010611A (es) * 2007-04-03 2010-03-26 Micromet Ag Enlazadores biespecificos, especificos para especies.
HUE040467T2 (hu) * 2007-04-03 2019-03-28 Amgen Res Munich Gmbh Keresztfaj-specifikus kötõdomén
JP2014500879A (ja) * 2010-11-16 2014-01-16 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｂｃｍａ発現に相関性を有する疾患を治療する因子及び方法
CN107903325B (zh) 2011-05-16 2021-10-29 埃泰美德(香港)有限公司 多特异性fab融合蛋白及其使用方法
RS58765B1 (sr) * 2011-05-21 2019-06-28 Macrogenics Inc Cd3-vezujući molekuli sposobni za vezivanje za humani i nehumani cd3
BR122021025087B1 (pt) 2013-12-17 2023-04-04 Genentech, Inc Anticorpo anti-cd3, célula hospedeira procariótica, método de produção do anticorpo biespecífico, imunoconjugado, composição, uso do anticorpo biespecífico e kit
AU2015266077A1 (en) * 2014-05-28 2016-09-29 F. Hoffmann-La Roche Ag Antibodies binding to human and cynomolgus CD3 epsilon
CN107108738A (zh) * 2014-07-25 2017-08-29 西托姆克斯治疗公司 抗cd3抗体、可活化抗cd3抗体、多特异性抗cd3抗体、多特异性可活化抗cd3抗体及其使用方法
AU2015295242B2 (en) * 2014-07-31 2020-10-22 Amgen Research (Munich) Gmbh Bispecific single chain antibody construct with enhanced tissue distribution
CN107709363A (zh) * 2015-05-01 2018-02-16 基因泰克公司 掩蔽抗cd3抗体和使用方法
US10870701B2 (en) 2016-03-15 2020-12-22 Generon (Shanghai) Corporation Ltd. Multispecific fab fusion proteins and use thereof
AU2017361081A1 (en) 2016-11-15 2019-05-23 Genentech, Inc. Dosing for treatment with anti-CD20/anti-CD3 bispecific antibodies
US10426424B2 (en) 2017-11-21 2019-10-01 General Electric Company System and method for generating and performing imaging protocol simulations
BR112020016169A2 (pt) 2018-02-08 2020-12-15 Genentech, Inc. Moléculas de ligação ao antígeno biespecíficas, ácido nucleico isolado, vetor, célula hospedeira, métodos para produzir a molécula de ligação, conjunto de ácidos nucleicos isolados, conjunto de vetores, conjunto de células hospedeiras, imunoconjugado, composição, uso da molécula de ligação, métodos para tratar ou retardar a progressão de um câncer, métodos para aperfeiçoar a função imune e kit
US20230067182A1 (en) * 2019-11-29 2023-03-02 Boe Technology Group Co., Ltd. Data Processing Device and Method, and Computer Readable Storage Medium
WO2021119505A1 (en) 2019-12-13 2021-06-17 Genentech, Inc. Anti-ly6g6d antibodies and methods of use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD272473B3 (de) * 1988-06-13 1993-01-21 Univ Leipzig Verfahren zur herstellung monoklonaler antikoerper gegen die epsilon-kettedes cd 3-antigens humaner t-lymphozyten
US7235641B2 (en) * 2003-12-22 2007-06-26 Micromet Ag Bispecific antibodies

Also Published As

Publication number Publication date
SI2155788T1 (sl) 2012-11-30
RU2009136913A (ru) 2011-06-20
RU2535992C2 (ru) 2014-12-20
NZ580746A (en) 2012-05-25
PT2155788E (pt) 2012-09-25
ES2390243T3 (es) 2012-11-07
DK2155788T3 (da) 2012-10-08
JP2010524435A (ja) 2010-07-22

Similar Documents

Publication Publication Date Title
RS52492B (en) MOLECULES WHICH INTERSPECIALLY SPECIFICALLY BISPECIFICALLY Bind
RS54900B1 (sr) Interspecijski specifično psmaxcd3 bispecifično jednolančano antitelo
RS53008B (en) INTERSPECTION SPECIFIC CD3-EPSILON BINDING DOMAIN
NZ602209A (en) Cross-species-specific psmaxcd3 bispecific single chain antibody
RS53594B1 (en) PREPARAT HER2 ANTITELA
RS54675B1 (en) MONOVALENT MIXTURES FOR CD28 BINDING AND METHODS OF USE
TW200745164A (en) Gene recombination antibodies composition
RU2019100481A (ru) Биспецифические антитела-ингибиторы контрольных точек
EP2987806A3 (en) Modified single variable domain antibodies with reduced binding to anti-drug-antibodies
RU2014144143A (ru) Химерные антигенные рецепторы, нацеленные на антиген созревания в-клеток
RS54359B1 (en) ANTI CD37 ANTIBODIES
RS52484B (en) CD40 ANTIBODIES
EA200870555A1 (ru) Слитые белки, их применение и способы их получения
RU2013110875A (ru) БИСПЕЦИФИЧЕСКИЕ АНТИТЕЛА, СОДЕРЖАЩИЕ СТАБИЛИЗИРОВАННЫЙ ДИСУЛЬФИДОМ ФРАГМЕНТ Fv
CO5261584A1 (es) Anticuerpos para il-1 humana
RS54424B1 (en) HUMAN ANTIBODIES CONCERNING CXCR4 AND THEIR USES
AR069681A1 (es) Moleculas de union al receptor ox40 humano
NZ590668A (en) TNF-alpha ANTAGONIST MULTI-TARGET BINDING PROTEINS
NZ716762A (en) Specific binding proteins and uses thereof
ATE408624T1 (de) Verfahren zur reinigung von fsh
RS54299B1 (en) COMPOSITIONS AND METHODS OF USING THERAPY ANTIBODIES
PE20081250A1 (es) FUSIONES Fc CON RECEPTOR PARA FGF SOLUBLE MODIFICADAS, CON ACTIVIDAD BIOLOGICA MEJORADA
SG10201807877TA (en) Hybrid immunoglobulin containing non-peptidyl linkage
BR0314814A (pt) Variantes otimizadas de fc e métodos para sua geração
WO2005066867A3 (en) Modulators of cell-surface receptors of the ig-class